Cargando…

New Host-Directed Therapeutics for the Treatment of Clostridioides difficile Infection

Frequent and excessive use of antibiotics primes patients to Clostridioides difficile infection (CDI), which leads to fatal pseudomembranous colitis, with limited treatment options. In earlier reports, we used a drug repurposing strategy and identified amoxapine (an antidepressant), doxapram (a brea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andersson, Jourdan A., Peniche, Alex G., Galindo, Cristi L., Boonma, Prapaporn, Sha, Jian, Luna, Ruth Ann, Savidge, Tor C., Chopra, Ashok K., Dann, Sara M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064747/ https://www.ncbi.nlm.nih.gov/pubmed/32156806 http://dx.doi.org/10.1128/mBio.00053-20

Ejemplares similares

Complete Genome Sequence of Clostridioides difficile Ribotype 255 Strain Mta-79, Assembled Using Oxford Nanopore and Illumina Sequencing
por: Spinler, Jennifer K., et al.
Publicado: (2019)

Bile acid-independent protection against Clostridioides difficile infection
por: Aguirre, Andrea Martinez, et al.
Publicado: (2021)

Neonatal Antibiotics Disrupt Motility and Enteric Neural Circuits in Mouse Colon
por: Hung, Lin Y., et al.
Publicado: (2019)

674. Host and Pathogen Risk Factors for Fulminant Clostridioides difficile Infection
por: Chua, Hubert C, et al.
Publicado: (2023)

Epidemic Clostridioides difficile Ribotype 027 Lineages: Comparisons of Texas Versus Worldwide Strains
por: Endres, Bradley T, et al.
Publicado: (2019)

The Enterotoxicity of Clostridium difficile Toxins
por: Sun, Xingmin, et al.
Publicado: (2010)

Host Immune Responses to Clostridioides difficile: Toxins and Beyond
por: Nibbering, Britt, et al.
Publicado: (2021)

An intact S-layer is advantageous to Clostridioides difficile within the host
por: Ormsby, Michael J., et al.
Publicado: (2023)

Systems biology approach to functionally assess the Clostridioides difficile pangenome reveals genetic diversity with discriminatory power
por: Norsigian, Charles J., et al.
Publicado: (2022)

Fecal microbiota transplantation for recurrent Clostridioides difficile, safety, and pitfalls
por: Sandhu, Avnish, et al.
Publicado: (2021)

Gut microbiota and microbiota-based therapies for Clostridioides difficile infection
por: Chopra, Teena, et al.
Publicado: (2023)

Fecal host biomarkers predicting severity of Clostridioides difficile infection
por: Golizeh, Makan, et al.
Publicado: (2021)

Host and Clostridioides difficile-Response Modulated by Micronutrients and Glutamine: An Overview
por: Loureiro, Andréa V., et al.
Publicado: (2022)

Functional profile of host microbiome indicates Clostridioides difficile infection
por: Nzabarushimana, Etienne, et al.
Publicado: (2022)

Clostridioides difficile infection: traversing host–pathogen interactions in the gut
por: Cheng, Jeffrey K. J., et al.
Publicado: (2023)

Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)

A multisite genomic epidemiology study of Clostridioides difficile infections in the USA supports differential roles of healthcare versus community spread for two common strains
por: Miles-Jay, Arianna, et al.
Publicado: (2021)

Probiotic VSL#3 Treatment Reduces Colonic Permeability and Abdominal Pain Symptoms in Patients With Irritable Bowel Syndrome
por: Boonma, Prapaporn, et al.
Publicado: (2021)

Systems biology analysis of the Clostridioides difficile core-genome contextualizes microenvironmental evolutionary pressures leading to genotypic and phenotypic divergence
por: Norsigian, Charles J., et al.
Publicado: (2020)

Lactobacillus rhamnosus L34 and Lactobacillus casei L39 suppress Clostridium difficile-induced IL-8 production by colonic epithelial cells
por: Boonma, Prapaporn, et al.
Publicado: (2014)

Integrating gut microbiome and host immune markers to understand the pathogenesis of Clostridioides difficile infection
por: Ke, Shanlin, et al.
Publicado: (2021)

Emerging Options for the Prevention and Management of Clostridioides difficile Infection
por: Gonzales-Luna, Anne J., et al.
Publicado: (2023)

The Association between GABA-Modulators and Clostridium difficile Infection – A Matched Retrospective Case-Control Study
por: Ström, Jonathan, et al.
Publicado: (2017)

ZupT Facilitates Clostridioides difficile Resistance to Host-Mediated Nutritional Immunity
por: Zackular, Joseph P., et al.
Publicado: (2020)

Host Immune Responses to Surface S-Layer Proteins (SLPs) of Clostridioides difficile
por: Chandra, Harish, et al.
Publicado: (2023)

Iron Regulation in Clostridioides difficile
por: Berges, Mareike, et al.
Publicado: (2018)

Extraintestinal Clostridioides difficile infection
por: Hai, Zhao, et al.
Publicado: (2020)

Pathogenicity and virulence of Clostridioides difficile
por: Buddle, Jessica E., et al.
Publicado: (2023)

The Clinical Burden of Clostridioides difficile in Ontario, Canada
por: Pereira, Jennifer A, et al.
Publicado: (2019)

Host immunity modulates the efficacy of microbiota transplantation for treatment of Clostridioides difficile infection
por: Littmann, Eric R., et al.
Publicado: (2021)

Pathobionts: mechanisms of survival, expansion, and interaction with host with a focus on Clostridioides difficile
por: Chandra, Harish, et al.
Publicado: (2021)

Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection
por: Ahn, Seung Woo, et al.
Publicado: (2021)

Simultaneous detection and ribotyping of Clostridioides difficile, and toxin gene detection directly on fecal samples
por: van Rossen, Tessel M., et al.
Publicado: (2021)

Role of the microbiome in essential metabolism in the human gut and its implications for Clostridioides difficile infection
por: Chopra, Teena, et al.
Publicado: (2023)

Metabolism the Difficile Way: The Key to the Success of the Pathogen Clostridioides difficile
por: Neumann-Schaal, Meina, et al.
Publicado: (2019)

1197. Inhibitory Effect of Ursodeoxycholic Acid on Clostridioides difficile Growth
por: Alnezary, Faris, et al.
Publicado: (2020)

Clostridioides difficile therapeutics: guidelines and beyond
por: Orenstein, Robert, et al.
Publicado: (2019)

Impact of ribotype on Clostridioides difficile diagnostics
por: Rizzardi, Kristina, et al.
Publicado: (2019)

Clostridioides (Clostridium) difficile Pacemaker Infection
por: Berkefeld, Anna, et al.
Publicado: (2020)

Opportunities for Nanomedicine in Clostridioides difficile Infection
por: Wang, Pei-Wen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_db9paeito44vbmqr6hj6630dqn